Why the study?
Does paclitaxel infusion affect cardiac ejection fraction in patients with high-risk features?
Does paclitaxel infusion affect cardiac ejection fraction in patients with high-risk features?
Paclitaxel has cardiotoxic effects that require careful monitoring of cardiac function during and after infusion in high-risk patients.
Paclitaxel has cardiotoxic effects. Careful monitoring of cardiac function during and after paclitaxel infusion is required in patients with high-risk features.
No takes yet. Share an insight, caveat, or question.
Osman et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: